Descovy and Clopidogrel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Descovy (emtricitabine; tenofovir alafenamide fumarate) and Clopidogrel (clopidogrel). Common drug interactions include bone pain among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Descovy and Clopidogrel. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.
What is Descovy?
Descovy has active ingredients of emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 14,260 Descovy users. Check the latest studies of Descovy.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
64 people who take Descovy and Clopidogrel together, and have interactions are studied.

What are the common drug interactions of Descovy and Clopidogrel, by gender? *:
female:
- Bone pain
- Chronic kidney disease
- Cough
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Fracture
- Gingival bleeding (bleeding gums)
- Hand fracture
- Heart rate increased
- Multiple fractures
- Pruritus (severe itching of the skin)
male:
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Bone density decreased
- Osteoporosis (bones weak and more likely to break)
- Abdominal discomfort
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Mobility decreased (ability to move is reduced)
- Surgery
- Renal impairment (severely reduced kidney function)
- Urinary tract infection
What are the common drug interactions of Descovy and Clopidogrel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Foot fracture
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Renal impairment (severely reduced kidney function)
- Rib fracture
- Sensory loss (senses loss)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bone density decreased
- Emotional distress
50-59:
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Arrhythmia (irregular heartbeat)
- Osteoporosis (bones weak and more likely to break)
- Asthenia (weakness)
- Blood creatinine increased
- Bone density decreased
- Depression
60+:
- Abdominal discomfort
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Bone pain
- Chronic kidney disease
- Death
- Gait disturbance
- Mobility decreased (ability to move is reduced)
- Angioedema (rapid swelling of the dermis)
- Diarrhoea
- Glomerular filtration rate decreased
What are the existing conditions these people have? *
- Insomnia (sleeplessness): 19 people, 29.69%
- Stable Angina (a constant chest pain): 13 people, 20.31%
- High Blood Pressure: 13 people, 20.31%
- Stress And Anxiety: 10 people, 15.62%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 10 people, 15.62%
- Diabetes: 9 people, 14.06%
- Neuropathy Peripheral (surface nerve damage): 7 people, 10.94%
- Hypotension (abnormally low blood pressure): 7 people, 10.94%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 10.94%
- Cellulitis (infection under the skin): 7 people, 10.94%
* Approximation only. Some reports may have incomplete information.
Do you take Descovy and Clopidogrel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Descovy (14,260 reports)
- Clopidogrel (92,160 reports)
Browse all drug interactions of Descovy and Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Descovy:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Descovy and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clopidogrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on emtricitabine; tenofovir alafenamide fumarate and clopidogrel (the active ingredients of Descovy and Clopidogrel, respectively), and Descovy and Clopidogrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ketotifen Fumarate and Mechanical Urticaria for Women aged 30-39 - 4 seconds ago
- Could Nicotine Polacrilex cause Oropharyngeal Discomfort? - 19 seconds ago
- Could Nitrolingual Pumpspray cause Fall? - 20 seconds ago
- Lipidil vs. Fish Oil, side effect and effectiveness comparison - 23 seconds ago
- Could Novolog cause Mucosal Inflammation? - 38 seconds ago
- Left Ventricular End-Diastolic Pressure Increased and drugs of ingredients of furosemide - 39 seconds ago
- Acetaminophen and Wound Haemorrhage for Women aged 60+ - 42 seconds ago
- Could Mavik cause Stasis Dermatitis? - 50 seconds ago
- Drug interactions of Tramadol and Folex - 56 seconds ago
- Body Height Below Normal and Abdominal Pain Upper - a minute ago